300253.SZ SHZ
Winning Health Technology Group Co., Ltd.
1W: -2.4%
1M: -1.3%
3M: +1.3%
YTD: -38.2%
1Y: -33.3%
3Y: -0.1%
5Y: -57.5%
¥6.98 ($1.04)
+0.02 (+0.29%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$408M
+120.5% ▲
5Y CAGR: +11.8%
Capital Expenditures
$306M
+2.4% ▲
5Y CAGR: +9.8%
Free Cash Flow
$102M
+179.1% ▲
5Y CAGR: +19.6%
Dividends Paid
$55M
-157.5% ▼
Buybacks
$80M
+0.0% ▲
Net Change in Cash
$229M
+249.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $506M | $354M | $15M | $318M | $50M |
| Depreciation & Amort. | $63M | $100M | $117M | $173M | $186M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$343M | -$379M | -$548M | -$726M | -$249M |
| Other Non-Cash Items | $165M | $294M | $444M | $667M | $421M |
| Operating Cash Flow | $390M | $368M | $100M | $185M | $408M |
| — Investing Activities — | |||||
| Capital Expenditures | -$187M | -$286M | -$324M | -$313M | -$306M |
| Acquisitions (Net) | -$11M | $343K | $3M | $135K | $0 |
| Investment Purchases | -$19M | -$81M | -$44M | -$47M | -$3M |
| Investment Sales | $130M | $24M | $18M | $90M | $8M |
| Other Investing | $475K | $4K | -$2M | $115K | $491K |
| Investing Cash Flow | -$86M | -$343M | -$350M | -$270M | -$300M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$12M | $748M | $43M | $19M | -$17M |
| Stock Repurchased | $0 | $0 | -$121M | $0 | -$80M |
| Dividends Paid | -$41M | -$54M | -$43M | -$21M | -$55M |
| Other Financing | $19M | -$119M | -$120M | -$67M | $274M |
| Financing Cash Flow | -$44M | $576M | -$120M | -$68M | $122M |
| Net Change in Cash | $261M | $601M | -$369M | -$154M | $229M |
| Cash End of Period | $965M | $1.6B | $1.2B | $1.0B | $1.3B |
| Free Cash Flow | $203M | $82M | -$223M | -$129M | $102M |